Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 10.63% is 2500% above its 5-year average of 0.41%, near the high end of its 5-year range (-98.58%–13.75%).
2.13% below its 12-month average of 10.86%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-27): 12.48%.
OPERATING MARGIN
10.63%
OPERATING MARGIN AVG TTM
10.86%
OPERATING MARGIN AVG 3Y
6.50%
OPERATING MARGIN AVG 5Y
0.41%
OPERATING MARGIN AVG 10Y
4.28%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2.13%
CURRENT VS 3Y AVG
+63.45%
CURRENT VS 5Y AVG
+2500.03%
CURRENT VS 10Y AVG
+148.37%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$887.99M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$884.97M
Operating Margin
-192.08%
TTM Avg
-714.41%
3Y Avg
-506.77%
5Y Avg
-588.71%
Market Cap
$870.81M
Operating Margin
-5415.19%
TTM Avg
-5415.19%
3Y Avg
-5415.19%
5Y Avg
-5415.19%
Market Cap
$867.03M
Operating Margin
-8.31%
TTM Avg
-16.09%
3Y Avg
-30.50%
5Y Avg
-38.64%
Market Cap
$914.73M
Operating Margin
8.04%
TTM Avg
6.98%
3Y Avg
6.09%
5Y Avg
5.66%
Market Cap
$857.16M
Operating Margin
-30.67%
TTM Avg
-52.06%
3Y Avg
-18.41%
5Y Avg
7.25%
Market Cap
$855.38M
Operating Margin
-1776.32%
TTM Avg
-888.16%
3Y Avg
-444.08%
5Y Avg
-444.08%
Market Cap
$921.06M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bioventus Inc. (BVS) | $887.50M | 10.63% | 10.86% | 6.50% | 0.41% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | -192.08% | -714.41% | -506.77% | -588.71% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $870.81M | -5415.19% | -5415.19% | -5415.19% | -5415.19% |
| SI-BONE, Inc. (SIBN)vs › | $867.03M | -8.31% | -16.09% | -30.50% | -38.64% |
| HealthStream, Inc. (HSTM)vs › | $914.73M | 8.04% | 6.98% | 6.09% | 5.66% |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | -30.67% | -52.06% | -18.41% | 7.25% |
| Alumis Inc. (ALMS)vs › | $855.38M | -1776.32% | -888.16% | -444.08% | -444.08% |
| MoonLake Immunotherapeutics (MLTX)vs › | $921.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 42.63% | 28.06% | -1.90% | -7.11% |
Gross Margin
68.0%
Operating Margin
10.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-27 | 12.48% |
| 2026-03-28 | 6.73% |
| 2025-12-31 | 13.75% |
| 2025-09-27 | 8.73% |
| 2025-06-28 | 12.61% |
| 2025-03-29 | 4.01% |
| 2024-12-31 | 5.20% |
| 2024-09-28 | 2.93% |
| 2024-06-29 | -20.81% |
| 2024-03-30 | 3.81% |
| 2023-12-31 | 0.86% |
| 2023-09-30 | 2.00% |
| 2023-07-01 | 4.92% |
| 2023-04-01 | -77.32% |
| 2022-12-31 | -20.21% |
| 2022-10-01 | -98.58% |
| 2022-07-02 | -2.36% |
| 2022-04-02 | -18.29% |
| 2021-12-31 | -2.42% |
| 2021-10-02 | -0.96% |
| 2021-07-03 | -5.23% |
| 2021-04-03 | 26.90% |
| 2020-12-31 | 5.99% |
| 2020-09-30 | 8.07% |
| 2020-06-30 | -7.92% |
| 2020-03-28 | 16.52% |
| 2019-12-06 | 14.05% |
| 2019-12-06 | 12.90% |
| 2019-06-29 | 4.30% |
| 2019-03-29 | 4.30% |
| 2016-03-31 | -3.12% |
| 2015-03-31 | -30.54% |
